TAAR1 and attention deficit-hyperactivity disorder: Thus, vLDX-derived activation of TAAR1 reinforced other monoamine-related vLDX effects mediated by targets, improving neurotransmitter regulation and affecting other relevant processes in ADHD (i.e., neuroplasticity, neuronal survival, and neuroinflammation).